Who we are

Support us

Career opportunities

Areas of Research

Principal Investigators

president's office
scientific director's office
newsroom
publications
events & seminars
diseases we fight
technology development
center for human cell therapy
research administration
core facilities
image gallery
search
directory
contact / directions
employee intranet
employee email
The Emerging Face of AIDS - Lieberman Lab Receives New Grant to Develop an RNAi-based Microbicide vs. HIV

The Emerging Face of AIDS

Lieberman Lab Receives New Grant to Develop an RNAi-based Microbicide vs. HIV
Increasingly, AIDS patients are women - especially women who cannot protect themselves against infection. CBRI scientists are responding to this issue through a new $7.8 million grant that will test the power of RNA interference technology as the basis of an anti-HIV microbicide more >>

The Emerging Face of AIDS

The Emerging Face of AIDS - Lieberman Lab Receives New Grant to Develop an RNAi-based Microbicide vs. HIV

Lieberman Lab Receives New Grant to Develop an RNAi-based Microbicide vs. HIV

Learn more >>

Shedding Light on Life
Advances in optical microscopy reveal biological processes as they unfold
more >>

IDI Investigator Motomu Shimaoka, recently promoted to Assoc Prof in Anesthesiology at HMS, reports:
In a technical advance for therapeutic RNA, (clockwise from top) Dan Peer, Christopher Carman, Eun Jeong Park, Yoshiyuki Morishita, and Motomu Shimaoka devised a novel nanoscale delivery particle that deposits siRNAs in hard-to-target immune cells. The particles calmed intestinal inflammation in mice by silencing the cyclin D1 gene
more >>

MicroRNA regulates cancer stem cells
One of the biggest stories in cancer research over the past few years has been, unexpectedly, stem cells. Not embryonic stem cells, but tumor stem cells.
more >>

 

© 2004 The Immune Disease Institute All rights reserved.
800 Huntington Avenue, Boston, Massachusetts, 02115

 
Harvard Medical School Affiliate
The CBR Institute for Biomedical Research

CBRI has, in order to reflect its principal research programs, taken the new name of Immune Disease Institute. To celebrate this important milestone in our history, we are creating a new web site. We look forward to sharing it with you in the fall.